Effect of nutrition on neurodegenerative diseases. A systematic review

References

• Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10(9):819–28.
   PubMed Web of Science ®Google Scholar
• Lardenoije R, van den Hove DLA, Havermans M, van Casteren A, Le KX, Palmour R, et al. Age-related epigenetic changes in hippocampal subregions of four animal models of Alzheimer's disease. Mol Cell Neurosci. 2018;86:1–15.
   PubMed Web of Science ®Google Scholar
• Reitz C, Mayeux R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol. 2014;88(4):640–51.
   PubMed Web of Science ®Google Scholar
• Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(8).
   PubMed Web of Science ®Google Scholar
• Niu H, Alvarez-Alvarez I, Guillen-Grima F, Al-Rahamneh MJ, Aguinaga-Ontoso I. Trends of mortality from Alzheimer's disease in the European Union, 1994-2013. Eur J Neurol. 2017;24(6):858–66.
   PubMed Web of Science ®Google Scholar
• Baig SS, Strong M, Quarrell OW. The global prevalence of Huntington's disease: a systematic review and discussion. Neurodegener Dis Manag. 2016;6(4):331–43.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Nagaoka U, Nakayama Y, Kawata A, Kugimoto C, Kuroiwa Y, et al. Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan. Amyotroph Lateral Scler. 2012;13(4):363–6.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Brown J, Holland AJ, Fukuhara R, Hodges JR. Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002;73(4):371–6.
   PubMed Web of Science ®Google Scholar
• Droogsma E, van Asselt D, De Deyn PP. Weight loss and undernutrition in community-dwelling patients with Alzheimer's dementia: from population based studies to clinical management. Z Gerontol Geriatr. 2015;48(4):318–24.
   PubMed Web of Science ®Google Scholar
• Hsu DC, Mormino EC, Schultz AP, Amariglio RE, Donovan NJ, Rentz DM, et al. Lower late-life body-mass index is associated with higher cortical amyloid burden in clinically normal elderly. J Alzheimers Dis. 2016;53(3):1097–105.
   PubMed Web of Science ®Google Scholar
• Herrup K. Reimagining Alzheimer's disease–an age-based hypothesis. J Neurosci. 2010;30(50):16755–62.
   PubMed Web of Science ®Google Scholar
• Tenkorang MA, Snyder B, Cunningham RL. Sex-related differences in oxidative stress and neurodegeneration. Steroids. 2018;133:21–7.
   PubMed Web of Science ®Google Scholar
• Gratwicke J, Jahanshahi M, Foltynie T. Parkinson's disease dementia: a neural networks perspective. Brain. 2015;138(Pt 6):1454–76.
   PubMed Web of Science ®Google Scholar
• Bohnen NI, Kaufer DI, Ivanco LS, Lopresti B, Koeppe RA, Davis JG, et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol. 2003;60(12):1745–8.
   PubMed Web of Science ®Google Scholar
• Ashraghi MR, Pagano G, Polychronis S, Niccolini F, Politis M. Parkinson's disease, diabetes and cognitive impairment. Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):11–21.
   PubMed Web of Science ®Google Scholar
• Bosco D, Plastino M, Cristiano D, Colica C, Ermio C, De Bartolo M, et al. Dementia is associated with insulin resistance in patients with Parkinson's disease. J Neurol Sci. 2012;315(1-2):39–43.
   PubMed Web of Science ®Google Scholar
• Oh J, An JW, Oh SI, Oh KW, Kim JA, Lee JS, et al. Socioeconomic costs of amyotrophic lateral sclerosis according to staging system. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(3-4):202–8.
   PubMed Web of Science ®Google Scholar
• del Aguila MA, Longstreth WT, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003;60(5):813–9.
   PubMed Web of Science ®Google Scholar
• Arthur KC, Calvo A, Price TR, Geiger JT, Chio A, Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7:12408.
   PubMed Web of Science ®Google Scholar
• Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol. 2011;7(11):616–30.
   PubMed Web of Science ®Google Scholar
• Riancho J, Bosque-Varela P, Perez-Pereda S, Povedano M, de Munain AL, Santurtun A. The increasing importance of environmental conditions in amyotrophic lateral sclerosis. Int J Biometeorol. 2018;62(8):1361–74.
   PubMed Web of Science ®Google Scholar
• Celeste DB, Miller MS. Reviewing the evidence for viruses as environmental risk factors for ALS: a new perspective. Cytokine. 2018;108:173–8.
   PubMed Web of Science ®Google Scholar
• Joardar A, Manzo E, Zarnescu DC. Metabolic dysregulation in amyotrophic lateral sclerosis: challenges and Opportunities. Curr Genet Med Rep. 2017;5(2):108–14.
   PubMedGoogle Scholar
• D'Amico E, Factor-Litvak P, Santella RM, Mitsumoto H. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med. 2013;65:509–27.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Kihira T, Kondo T, Kobashi G, Washio M, Sasaki S, et al. Nutritional status and risk of amyotrophic lateral sclerosis in Japan. Amyotroph Lateral Scler. 2007;8(5):300–4.
   PubMed Web of Science ®Google Scholar
• O'Reilly EJ, Wang H, Weisskopf MG, Fitzgerald KC, Falcone G, McCullough ML, et al. Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(3):205–11.
   PubMed Web of Science ®Google Scholar
• Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44(1):20–4.
   PubMed Web of Science ®Google Scholar
• Ahmed RM, Caga J, Devenney E, Hsieh S, Bartley L, Highton-Williamson E, et al. Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival. J Neurol. 2016;263(8):1593–603.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study. Arch Neurol. 2000;57(8):1171–6.
   PubMed Web of Science ®Google Scholar
• Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013;14(4):248–64.
   PubMed Web of Science ®Google Scholar
• Karussis D. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun. 2014;48-49:134–42.
   PubMed Web of Science ®Google Scholar
• Dutta R, Trapp BD. Relapsing and progressive forms of multiple sclerosis: insights from pathology. Curr Opin Neurol. 2014;27(3):271–8.
   PubMed Web of Science ®Google Scholar
• Grytten N, Torkildsen O, Myhr KM. Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades. Acta Neurol Scand. 2015;132(199):29–36.
   PubMedGoogle Scholar
• Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, et al. Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity. Neurology. 2014;83(11):1022–4.
   PubMed Web of Science ®Google Scholar
• Passos GR D, Sato DK, Becker J, Fujihara K. Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications. Mediators Inflamm. 2016;2016:5314541.
   PubMed Web of Science ®Google Scholar
• Wu H, Zhao M, Yoshimura A, Chang C, Lu Q. Critical link between epigenetics and transcription factors in the induction of autoimmunity: a comprehensive review. Clin Rev Allergy Immunol. 2016;50(3):333–44.
   PubMed Web of Science ®Google Scholar
• McLeod JG, Hammond SR, Kurtzke JF. Migration and multiple sclerosis in United Kingdom and Ireland immigrants to Australia: a reassessment. II. characteristics of early (pre-1947) compared to later migrants. J Neurol. 2012;259(4):684–93.
   PubMed Web of Science ®Google Scholar
• Riemann-Lorenz K, Eilers M, von Geldern G, Schulz KH, Kopke S, Heesen C. Dietary interventions in multiple sclerosis: development and pilot-testing of an evidence based patient education program. PLoS One. 2016;11(10):e0165246.
   PubMed Web of Science ®Google Scholar
• Farinotti M, Vacchi L, Simi S, Di Pietrantonj C, Brait L, Filippini G. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev. 2012;12:CD004192.
   PubMedGoogle Scholar
• Landles C, Bates GP. Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep. 2004;5(10):958–63.
   PubMed Web of Science ®Google Scholar
• Sharma S, Taliyan R. Transcriptional dysregulation in Huntington's disease: the role of histone deacetylases. Pharmacol Res. 2015;100:157–69.
   PubMed Web of Science ®Google Scholar
• Ehrnhoefer DE, Butland SL, Pouladi MA, Hayden MR. Mouse models of Huntington disease: variations on a theme. Dis Model Mech. 2009;2(3-4):123–9.
   PubMed Web of Science ®Google Scholar
• Damiano M, Galvan L, Deglon N, Brouillet E. Mitochondria in Huntington's disease. Biochim Biophys Acta. 2010;1802(1802):52–61.
   PubMedGoogle Scholar
• Sussmuth SD, Muller VM, Geitner C, Landwehrmeyer GB, Iff S, Gemperli A, et al. Fat-free mass and its predictors in Huntington's disease. J Neurol. 2015;262(6):1533–40.
   PubMed Web of Science ®Google Scholar
• Jucker M, Walker LC. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol. 2011;70(4):532–40.
   PubMed Web of Science ®Google Scholar
• Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;(10 Suppl):S10–7.
   PubMedGoogle Scholar
• Manoharan S, Guillemin GJ, Abiramasundari RS, Essa MM, Akbar M, Akbar MD. The role of reactive oxygen species in the pathogenesis of Alzheimer's disease, Parkinson's disease, and huntington's disease: a mini review. Oxid Med Cell Longev. 2016;2016:8590578.
   PubMed Web of Science ®Google Scholar
• Liang JH, Xu Y, Lin L, Jia RX, Zhang HB, Hang L. Comparison of multiple interventions for older adults with Alzheimer disease or mild cognitive impairment: a PRISMA-compliant network meta-analysis. Medicine (Baltimore. 2018;97(20):e10744.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
   PubMed Web of Science ®Google Scholar
• Young KW, Greenwood CE, van Reekum R, Binns MA. Providing nutrition supplements to institutionalized seniors with probable Alzheimer's disease is least beneficial to those with low body weight status. J Am Geriatr Soc. 2004;52(8):1305–12.
   PubMed Web of Science ®Google Scholar
• Fillenbaum GG, Kuchibhatla MN, Hanlon JT, Artz MB, Pieper CF, Schmader KE, et al. Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E. Ann Pharmacother. 2005;39(12):2009–14.
   PubMed Web of Science ®Google Scholar
• Remington R, Bechtel C, Larsen D, Samar A, Page R, Morrell C, et al. Maintenance of cognitive performance and mood for individuals with Alzheimer's disease following consumption of a nutraceutical formulation: a one-year, open-label study. J Alzheimers Dis. 2016;51(4):991–5.
   PubMed Web of Science ®Google Scholar
• Rotstein DL, Cortese M, Fung TT, Chitnis T, Ascherio A, Munger KL. Diet quality and risk of multiple sclerosis in two cohorts of US women. Mult Scler. 2018.
   Google Scholar
• Baleztena J, Ruiz-Canela M, Sayon-Orea C, Pardo M, Anorbe T, Gost JI, et al. Association between cognitive function and supplementation with omega-3 PUFAs and other nutrients in >/ = 75 years old patients: a randomized multicenter study. PLoS One. 2018;13(3):e0193568.
   PubMed Web of Science ®Google Scholar
• Berti V, Walters M, Sterling J, Quinn CG, Logue M, Andrews R, et al. Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults. Neurology. 2018;90(20):e1789–e98.
   PubMed Web of Science ®Google Scholar
• Nieves JW, Gennings C, Factor-Litvak P, Hupf J, Singleton J, Sharf V, et al. Association between dietary intake and function in amyotrophic lateral sclerosis. JAMA Neurol. 2016;73(12):1425–32.
   PubMed Web of Science ®Google Scholar
• Anastasiou CA, Yannakoulia M, Kosmidis MH, Dardiotis E, Hadjigeorgiou GM, Sakka P, et al. Mediterranean diet and cognitive health: initial results from the hellenic longitudinal investigation of ageing and diet. PLoS One. 2017;12(8):e0182048.
   PubMed Web of Science ®Google Scholar
• Knight A, Bryan J, Wilson C, Hodgson JM, Davis CR, Murphy KJ. The Mediterranean diet and cognitive function among healthy older adults in a 6-month randomised controlled trial: the MedLey study. Nutrients. 2016;8(9.
   PubMed Web of Science ®Google Scholar
• Olsson E, Karlstrom B, Kilander L, Byberg L, Cederholm T, Sjogren P. Dietary patterns and cognitive dysfunction in a 12-year follow-up study of 70 year old men. J Alzheimers Dis. 2015;43(1):109–19.
   PubMed Web of Science ®Google Scholar
• Qin B, Adair LS, Plassman BL, Batis C, Edwards LJ, Popkin BM, et al. Dietary patterns and cognitive decline Among Chinese older adults. Epidemiology. 2015;26(5):758–68.
   PubMed Web of Science ®Google Scholar
• Trichopoulou A, Kyrozis A, Rossi M, Katsoulis M, Trichopoulos D, La Vecchia C, et al. Mediterranean diet and cognitive decline over time in an elderly Mediterranean population. Eur J Nutr. 2015;54(8):1311–21.
   PubMed Web of Science ®Google Scholar
• Valls-Pedret C, Sala-Vila A, Serra-Mir M, Corella D, de la Torre R, Martinez-Gonzalez MA, et al. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med. 2015;175(7):1094–103.
   PubMed Web of Science ®Google Scholar
• Zbeida M, Goldsmith R, Shimony T, Vardi H, Naggan L, Shahar DR. Mediterranean diet and functional indicators among older adults in non-Mediterranean and Mediterranean countries. J Nutr Health Aging. 2014;18(4):411–8.
   PubMed Web of Science ®Google Scholar
• Mosconi L, Murray J, Tsui WH, Li Y, Davies M, Williams S, et al. Mediterranean diet and magnetic resonance imaging-assessed brain atrophy in cognitively normal individuals at risk for Alzheimer's disease. J Prev Alzheimers Dis. 2014;1(1):23–32.
   PubMedGoogle Scholar
• Ozawa M, Ninomiya T, Ohara T, Doi Y, Uchida K, Shirota T, et al. Dietary patterns and risk of dementia in an elderly Japanese population: the Hisayama study. Am J Clin Nutr. 2013;97(5):1076–82.
   PubMed Web of Science ®Google Scholar
• Marder K, Gu Y, Eberly S, Tanner CM, Scarmeas N, Oakes D, et al. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. JAMA Neurol. 2013;70(11):1382–8.
   PubMed Web of Science ®Google Scholar
• Martinez-Lapiscina EH, Clavero P, Toledo E, Estruch R, Salas-Salvado J, San Julian B, et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry. 2013;84(12):1318–25.
   PubMed Web of Science ®Google Scholar
• Kesse-Guyot E, Andreeva VA, Lassale C, Ferry M, Jeandel C, Hercberg S, et al. Mediterranean diet and cognitive function: a French study. Am J Clin Nutr. 2013;97(2):369–76.
   PubMed Web of Science ®Google Scholar
• Ye X, Scott T, Gao X, Maras JE, Bakun PJ, Tucker KL. Mediterranean diet, healthy eating index 2005, and cognitive function in middle-aged and older Puerto Rican adults. J Acad Nutr Diet. 2013;113(2):276–81 e1-3.
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Judd S, Letter AJ, Alexandrov AV, Howard G, Nahab F, et al. Adherence to a Mediterranean diet and risk of incident cognitive impairment. Neurology. 2013;80(18):1684–92.
   PubMed Web of Science ®Google Scholar
• Samieri C, Grodstein F, Rosner BA, Kang JH, Cook NR, Manson JE, et al. Mediterranean diet and cognitive function in older age. Epidemiology. 2013;24(4):490–9.
   PubMed Web of Science ®Google Scholar
• Cherbuin N, Anstey KJ. The Mediterranean diet is not related to cognitive change in a large prospective investigation: the PATH through life study. Am J Geriatr Psychiatry. 2012;20(7):635–9.
   PubMed Web of Science ®Google Scholar
• Vercambre MN, Grodstein F, Berr C, Kang JH. Mediterranean diet and cognitive decline in women with cardiovascular disease or risk factors. J Acad Nutr Diet. 2012;112(6):816–23.
   PubMed Web of Science ®Google Scholar
• Tangney CC, Kwasny MJ, Li H, Wilson RS, Evans DA, Morris MC. Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population. Am J Clin Nutr. 2011;93(3):601–7.
   PubMed Web of Science ®Google Scholar
• Gu Y, Brickman AM, Stern Y, Habeck CG, Razlighi QR, Luchsinger JA, et al. Mediterranean diet and brain structure in a multiethnic elderly cohort. Neurology. 2015;85(20):1744–51.
   PubMed Web of Science ®Google Scholar
• Feart C, Samieri C, Rondeau V, Amieva H, Portet F, Dartigues JF, et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA. 2009;302(6):638–48.
   PubMed Web of Science ®Google Scholar
• Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N, Luchsinger JA. Mediterranean diet and mild cognitive impairment. Arch Neurol. 2009;66(2):216–25.
   PubMed Web of Science ®Google Scholar
• Scarmeas N, Luchsinger JA, Mayeux R, Stern Y. Mediterranean diet and Alzheimer disease mortality. Neurology. 2007;69(11):1084–93.
   PubMed Web of Science ®Google Scholar
• Wengreen H, Munger RG, Cutler A, Quach A, Bowles A, Corcoran C, et al. Prospective study of dietary approaches to Stop hypertension- and Mediterranean-style dietary patterns and age-related cognitive change: the cache county study on memory, health and aging. Am J Clin Nutr. 2013;98(5):1263–71.
   PubMed Web of Science ®Google Scholar
• Gardener S, Gu Y, Rainey-Smith SR, Keogh JB, Clifton PM, Mathieson SL, et al. Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population. Transl Psychiatry. 2012;2:e164.
   PubMed Web of Science ®Google Scholar
• Gu Y, Luchsinger JA, Stern Y, Scarmeas N. Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease. J Alzheimers Dis. 2010;22(2):483–92.
   PubMed Web of Science ®Google Scholar
• Tamtaji OR, Heidari-Soureshjani R, Mirhosseini N, Kouchaki E, Bahmani F, Aghadavod E, et al. Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: a randomized, double-blind, controlled trial. Clin Nutr. 2018;12:S0261–5614.
   Google Scholar
• Kouchaki E, Tamtaji OR, Salami M, Bahmani F, Daneshvar Kakhaki R, Akbari E, et al. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2017;36(5):1245–9.
   PubMed Web of Science ®Google Scholar
• Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji OR, et al. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: a randomized, double-blind and controlled trial. Front Aging Neurosci. 2016;8:256.
   PubMed Web of Science ®Google Scholar
• van der Zwaluw NL, van de Rest O, Tieland M, Adam JJ, Hiddink GJ, van Loon LJ, et al. The impact of protein supplementation on cognitive performance in frail elderly. Eur J Nutr. 2014;53(3):803–12.
   PubMed Web of Science ®Google Scholar
• Remington R, Lortie JJ, Hoffmann H, Page R, Morrell C, Shea TB. A nutritional formulation for cognitive performance in mild cognitive impairment: a placebo-controlled trial with an open-label extension. J Alzheimers Dis. 2015;48(3):591–5.
   PubMed Web of Science ®Google Scholar
• Suominen MH, Puranen TM, Jyvakorpi SK, Eloniemi-Sulkava U, Kautiainen H, Siljamaki-Ojansuu U, et al. Nutritional guidance improves nutrient intake and quality of life, and may prevent falls in aged persons with Alzheimer disease living with a Spouse (NuAD trial). J Nutr Health Aging. 2015;19(9):901–7.
   PubMed Web of Science ®Google Scholar
• Sheard JM, Ash S, Mellick GD, Silburn PA, Kerr GK. Improved nutritional status is related to improved quality of life in Parkinson's disease. BMC Neurol. 2014;14:212.
   PubMed Web of Science ®Google Scholar
• Kwok TC, Lam LC, Sea MM, Goggins W, Woo J. A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. Eur J Clin Nutr. 2012;66(10):1135–40.
   PubMed Web of Science ®Google Scholar
• Jyvakorpi SK, Puranen T, Pitkala KH, Suominen MH. Nutritional treatment of aged individuals with Alzheimer disease living at home with their spouses: study protocol for a randomized controlled trial. Trials. 2012;13:66.
   PubMedGoogle Scholar
• Pivi GA, da Silva RV, Juliano Y, Novo NF, Okamoto IH, Brant CQ, et al. A prospective study of nutrition education and oral nutritional supplementation in patients with Alzheimer's disease. Nutr J. 2011;10:98.
   PubMed Web of Science ®Google Scholar
• Salva A, Andrieu S, Fernandez E, Schiffrin EJ, Moulin J, Decarli B, et al. Health and nutritional promotion program for patients with dementia (NutriAlz study): design and baseline data. J Nutr Health Aging. 2009;13(6):529–37.
   PubMed Web of Science ®Google Scholar
• Salas-Salvado J, Torres M, Planas M, Altimir S, Pagan C, Gonzalez ME, et al. Effect of oral administration of a whole formula diet on nutritional and cognitive status in patients with Alzheimer's disease. Clin Nutr. 2005;24(3):390–7.
   PubMed Web of Science ®Google Scholar
• Trejo A, Boll MC, Alonso ME, Ochoa A, Velasquez L. Use of oral nutritional supplements in patients with Huntington's disease. Nutrition. 2005;21(9):889–94.
   PubMed Web of Science ®Google Scholar
• Lauque S, Arnaud-Battandier F, Gillette S, Plaze JM, Andrieu S, Cantet C, et al. Improvement of weight and fat-free mass with oral nutritional supplementation in patients with Alzheimer's disease at risk of malnutrition: a prospective randomized study. J Am Geriatr Soc. 2004;52(10):1702–7.
   PubMed Web of Science ®Google Scholar
• Gil Gregorio P, Ramirez Diaz SP, Ribera Casado JM. group D. dementia and nutrition. intervention study in institutionalized patients with Alzheimer disease. J Nutr Health Aging. 2003;7(5):304–8.
   PubMedGoogle Scholar
• Riviere S, Gillette-Guyonnet S, Voisin T, Reynish E, Andrieu S, Lauque S, et al. A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer's disease. J Nutr Health Aging. 2001;5(4):295–9.
   PubMedGoogle Scholar
• Soininen H, Solomon A, Visser PJ, Hendrix SB, Blennow K, Kivipelto M, et al. 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial. Lancet Neurol. 2017;16(12):965–75.
   PubMed Web of Science ®Google Scholar
• Salva A, Andrieu S, Fernandez E, Schiffrin EJ, Moulin J, Decarli B, et al. Health and nutrition promotion program for patients with dementia (NutriAlz): cluster randomized trial. J Nutr Health Aging. 2011;15(10):822–30.
   PubMed Web of Science ®Google Scholar
• Tamtaji OR, Taghizadeh M, Daneshvar Kakhaki R, Kouchaki E, Bahmani F, Borzabadi S, et al. Clinical and metabolic response to probiotic administration in people with Parkinson's disease: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2019;38(3):1031–5.
   PubMed Web of Science ®Google Scholar
• Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol. 2017;16(5):377–89.
   PubMed Web of Science ®Google Scholar
• Mazereeuw G, Herrmann N, Oh PI, Ma DW, Wang CT, Kiss A, et al. Omega-3 fatty acids, depressive symptoms, and cognitive performance in patients with coronary Artery disease: analyses from a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2016;36(5):436–44.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen J, Qiu J, Li Y, Wang J, Jiao J. Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies. Am J Clin Nutr. 2015;103(2):330–40.
   PubMed Web of Science ®Google Scholar
• Jackson PA, Forster JS, Bell JG, Dick JR, Younger I, Kennedy DO. Dha supplementation alone or in combination with other nutrients does not Modulate cerebral Hemodynamics or cognitive function in healthy older adults. Nutrients. 2016;8(2):86.
   PubMed Web of Science ®Google Scholar
• Kulzow N, Witte AV, Kerti L, Grittner U, Schuchardt JP, Hahn A, et al. Impact of omega-3 fatty acid supplementation on memory functions in healthy older adults. J Alzheimers Dis. 2016;51(3):713–25.
   PubMed Web of Science ®Google Scholar
• Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, Faxen-Irving G, et al. Plasma fatty acid profiles in relation to cognition and gender in Alzheimer's disease patients During oral omega-3 fatty acid supplementation: the OmegAD study. J Alzheimers Dis. 2015;48(3):805–12.
   PubMed Web of Science ®Google Scholar
• Chew EY, Clemons TE, Agron E, Launer LJ, Grodstein F, Bernstein PS, et al. Effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function: the AREDS2 randomized clinical trial. JAMA. 2015;314(8):791–801.
   PubMed Web of Science ®Google Scholar
• Phillips MA, Childs CE, Calder PC, Rogers PJ. No effect of omega-3 fatty acid supplementation on cognition and mood in individuals with cognitive impairment and probable Alzheimer's disease: a randomised controlled trial. Int J Mol Sci. 2015;16(10):24600–13.
   PubMed Web of Science ®Google Scholar
• Geleijnse JM, Giltay EJ, Kromhout D. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients. Alzheimers Dement. 2012;8(4):278–87.
   PubMed Web of Science ®Google Scholar
• Jaremka LM, Derry HM, Bornstein R, Prakash RS, Peng J, Belury MA, et al. Omega-3 supplementation and loneliness-related memory problems: secondary analyses of a randomized controlled trial. Psychosom Med. 2014;76(8):650–8.
   PubMed Web of Science ®Google Scholar
• Witte AV, Kerti L, Hermannstadter HM, Fiebach JB, Schreiber SJ, Schuchardt JP, et al. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex. 2014;24(11):3059–68.
   PubMed Web of Science ®Google Scholar
• Mahmoudi MJ, Hedayat M, Sharifi F, Mirarefin M, Nazari N, Mehrdad N, et al. Effect of low dose omega-3 poly unsaturated fatty acids on cognitive status among older people: a double-blind randomized placebo-controlled study. J Diabetes Metab Disord. 2014;13(1):34.
   PubMedGoogle Scholar
• Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010;6(6):456–64.
   PubMed Web of Science ®Google Scholar
• van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, Olderikkert MG, et al. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology. 2008;71(6):430–8.
   PubMed Web of Science ®Google Scholar
• Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. 2006;63(10):1402–8.
   PubMed Web of Science ®Google Scholar
• Jerneren F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain omega-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015;102(1):215–21.
   PubMed Web of Science ®Google Scholar
• Regitz C, Fitzenberger E, Mahn FL, Dussling LM, Wenzel U. Resveratrol reduces amyloid-beta (Abeta(1)(-)(4)(2))-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans. Eur J Nutr. 2016;55(2):741–7.
   PubMed Web of Science ®Google Scholar
• Yip PK, Pizzasegola C, Gladman S, Biggio ML, Marino M, Jayasinghe M, et al. The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis. PLoS One. 2013;8(4):e61626.
   PubMed Web of Science ®Google Scholar
• Kwok T, Lee J, Ma RC, Wong SY, Kung K, Lam A, et al. A randomized placebo controlled trial of vitamin B12 supplementation to prevent cognitive decline in older diabetic people with borderline low serum vitamin B12. Clin Nutr. 2017;36(6):1509–15.
   PubMed Web of Science ®Google Scholar
• Liu G, Zhao Y, Jin S, Hu Y, Wang T, Tian R, et al. Circulating vitamin E levels and Alzheimer's disease: a Mendelian randomization study. Neurobiol Aging. 2018;72:189 e1–e9.
   Web of Science ®Google Scholar
• Hiller AL, Murchison CF, Lobb BM. O'Connor S, O'Connor M, Quinn JF. A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson's disease: does age matter? PLoS One. 2018;13(9):e0203637.
   PubMed Web of Science ®Google Scholar
• Kryscio RJ, Abner EL, Caban-Holt A, Lovell M, Goodman P, Darke AK, et al. Association of antioxidant supplement Use and dementia in the prevention of Alzheimer's disease by vitamin E and selenium trial (PREADViSE). JAMA Neurol. 2017;74(5):567–73.
   PubMed Web of Science ®Google Scholar
• Chen H, Liu S, Ji L, Wu T, Ji Y, Zhou Y, et al. Folic acid supplementation mitigates Alzheimer's disease by reducing inflammation: a randomized controlled trial. Mediators Inflamm. 2016;2016:5912146.
   PubMed Web of Science ®Google Scholar
• Dangour AD, Allen E, Clarke R, Elbourne D, Fletcher AE, Letley L, et al. Effects of vitamin B-12 supplementation on neurologic and cognitive function in older people: a randomized controlled trial. Am J Clin Nutr. 2015;102(3):639–47.
   PubMed Web of Science ®Google Scholar
• van der Zwaluw NL, Dhonukshe-Rutten RA, van Wijngaarden JP, Brouwer-Brolsma EM, van de Rest O, In ‘t Veld PH, et al. Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT. Neurology. 2014;83(23):2158–66.
   PubMed Web of Science ®Google Scholar
• Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA. 2014;311(1):33–44.
   PubMed Web of Science ®Google Scholar
• Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, et al. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA. 2008;300(15):1774–83.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Weisskopf MG, O'Reilly E J, Jacobs EJ, McCullough ML, Calle EE, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann Neurol. 2005;57(1):104–10.
   PubMed Web of Science ®Google Scholar
• Dong R, Yang Q, Zhang Y, Li J, Zhang L, Zhao H. Meta-analysis of vitamin C, vitamin E and beta-carotene levels in the plasma of Alzheimer's disease patients]. Wei Sheng Yan Jiu. 2018;47(4):648–54.
   PubMedGoogle Scholar
• Lloret A, Badia MC, Mora NJ, Pallardo FV, Alonso MD, Vina J. Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental. J Alzheimers Dis. 2009;17(1):143–9.
   PubMed Web of Science ®Google Scholar
• Charlton KE, Rabinowitz TL, Geffen LN, Dhansay MA. Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. J Nutr Health Aging. 2004;8(2):99–107.
   PubMedGoogle Scholar
• Chandra RK. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition. 2001;17(9):709–12.
   PubMed Web of Science ®Google Scholar
• Carlson JJ, Farquhar JW, DiNucci E, Ausserer L, Zehnder J, Miller D, et al. Safety and efficacy of a ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults. J Am Diet Assoc. 2007;107(3):422–32.
   PubMedGoogle Scholar
• Shim JS, Oh K, Kim HC. Dietary assessment methods in epidemiologic studies. Epidemiol Health. 2014;36:e2014009.
   PubMedGoogle Scholar
• Pasinetti GM, Eberstein JA. Metabolic syndrome and the role of dietary lifestyles in Alzheimer's disease. J Neurochem. 2008;106(4):1503–14.
   PubMed Web of Science ®Google Scholar
• Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348(26):2599–608.
   PubMed Web of Science ®Google Scholar
• van Himbergen TM, Beiser AS, Ai M, Seshadri S, Otokozawa S, Au R, et al. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: results from the Framingham Heart study. Arch Neurol. 2012;69(5):594–600.
   PubMedGoogle Scholar
• Wu L, Sun D. Adherence to Mediterranean diet and risk of developing cognitive disorders: an updated systematic review and meta-analysis of prospective cohort studies. Sci Rep. 2017;7:41317.
   PubMed Web of Science ®Google Scholar
• Singh B, Parsaik AK, Mielke MM, Erwin PJ, Knopman DS, Petersen RC, et al. Association of Mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014;39(2):271–82.
   PubMed Web of Science ®Google Scholar
• Hanson LC, Ersek M, Lin FC, Carey, TS. Outcomes of feeding problems in advanced dementia in a nursing home population. J Am Geriatr Soc. 2013;61:1692–7.
   PubMed Web of Science ®Google Scholar
• Ticinesi A, Nouvenne A, Lauretani F, Prati B, Cerundolo N, Maggio M, et al. Survival in older adults with dementia and eating problems: to PEG or not to PEG? Clin Nutr. 2016;35(6):1512–6.
   PubMed Web of Science ®Google Scholar
• Ma K, Xiong N, Shen Y, Han C, Liu L, Zhang G, et al. Weight loss and malnutrition in patients with Parkinson's disease: current Knowledge and future Prospects. Front Aging Neurosci. 2018;10:1.
   Google Scholar
• Lorefalt B, Ganowiak W, Palhagen S, Toss G, Unosson M, Granerus AK. Factors of importance for weight loss in elderly patients with Parkinson's disease. Acta Neurol Scand. 2004;110(3):180–7.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Oh ES, Lee JH, Moon JS, Oh JE, Shin JW, et al. Relationship between changes of body mass index (BMI) and cognitive decline in Parkinson's disease (PD). Arch Gerontol Geriatr. 2012;55(1):70–2.
   PubMed Web of Science ®Google Scholar
• Gibas KJ. The starving brain: overfed meets undernourished in the pathology of mild cognitive impairment (MCI) and Alzheimer's disease (AD). Neurochem Int. 2017;110:57–68.
   PubMed Web of Science ®Google Scholar
• Cova I, Clerici F, Maggiore L, Pomati S, Cucumo V, Ghiretti R, et al. Body mass index Predicts progression of mild cognitive impairment to dementia. Dement Geriatr Cogn Disord. 2016;41(3-4):172–80.
   PubMed Web of Science ®Google Scholar
• Faxen-Irving G, Basun H, Cederholm T. Nutritional and cognitive relationships and long-term mortality in patients with various dementia disorders. Age Ageing. 2005;34(2):136–41.
   PubMed Web of Science ®Google Scholar
• Joo SH, Yun SH, Kang DW, Hahn CT, Lim HK, Lee CU. Body mass index in mild cognitive impairment According to Age, Sex, cognitive intervention, and hypertension and risk of progression to Alzheimer's disease. Front Psychiatry. 2018;9:142.
   PubMed Web of Science ®Google Scholar
• Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry. 2010;67(6):505–12.
   PubMed Web of Science ®Google Scholar
• Benstead T, Jackson-Tarlton C, Leddin D. Nutrition with gastrostomy feeding tubes for amyotrophic lateral sclerosis in Canada. Can J Neurol Sci. 2016;43(6):796–800.
   PubMed Web of Science ®Google Scholar
• Park Y, Park J, Kim Y, Baek H, Kim SH. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients. Nutrition. 2015;31(11-12):1362–7.
   PubMed Web of Science ®Google Scholar
• Mauriz E, Laliena A, Vallejo D, Tunon MJ, Rodriguez-Lopez JM, Rodriguez-Perez R, et al. Effects of a low-fat diet with antioxidant supplementation on biochemical markers of multiple sclerosis long-term care residents. Nutr Hosp. 2013;28(6):2229–35.
   PubMed Web of Science ®Google Scholar
• Burckhardt M, Herke M, Wustmann T, Watzke S, Langer G, Fink A. Omega-3 fatty acids for the treatment of dementia. Cochrane Database Syst Rev. 2016;4:CD009002.
   PubMedGoogle Scholar
• Knaze V, Rothwell JA, Zamora-Ros R, Moskal A, Kyro C, Jakszyn P, et al. A new food-composition database for 437 polyphenols in 19,899 raw and prepared foods used to estimate polyphenol intakes in adults from 10 European countries. Am J Clin Nutr. 2018.
   PubMed Web of Science ®Google Scholar
• Strathearn KE, Yousef GG, Grace MH, Roy SL, Tambe MA, Ferruzzi MG, et al. Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinsons disease. Brain Res. 2014;1555:60–77.
   PubMed Web of Science ®Google Scholar
• Granzotto A, Zatta P. Resveratrol and Alzheimer's disease: message in a bottle on red wine and cognition. Front Aging Neurosci. 2014;6:95.
   PubMed Web of Science ®Google Scholar
• Bastianetto S, Menard C, Quirion R. Neuroprotective action of resveratrol. Biochim Biophys Acta. 2015;1852(6):1195–201.
   PubMed Web of Science ®Google Scholar
• Braidy N, Jugder BE, Poljak A, Jayasena T, Mansour H, Nabavi SM, et al. Resveratrol as a potential therapeutic candidate for the treatment and management of Alzheimer's disease. Curr Top Med Chem. 2016;16(17):1951–60.
   PubMed Web of Science ®Google Scholar
• Xu W, Wang H, Wan Y, Tan C, Li J, Tan L, et al. Alcohol consumption and dementia risk: a dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2017;32(1):31–42.
   PubMed Web of Science ®Google Scholar
• Jia Y, Wang N, Liu X. Resveratrol and amyloid-Beta: mechanistic insights. Nutrients. 2017;9(10.
   Web of Science ®Google Scholar
• Freyssin A, Page G, Fauconneau B, Rioux Bilan A. Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases. Neural Regen Res. 2018;13(6):955–61.
   PubMed Web of Science ®Google Scholar
• Witte AV, Kerti L, Margulies DS, Floel A. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J Neurosci. 2014;34(23):7862–70.
   PubMed Web of Science ®Google Scholar
• Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127(6):1109–22.
   PubMed Web of Science ®Google Scholar
• Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337–42.
   PubMed Web of Science ®Google Scholar
• Tian Y, Ma J, Wang W, Zhang L, Xu J, Wang K, et al. Resveratrol supplement inhibited the NF-kappaB inflammation pathway through activating AMPKalpha-SIRT1 pathway in mice with fatty liver. Mol Cell Biochem. 2016;422(1-2):75–84.
   PubMed Web of Science ®Google Scholar
• Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys. 2010;501(1):79–90.
   PubMed Web of Science ®Google Scholar
• Donmez G, Wang D, Cohen DE, Guarente L. Sirt1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell. 2010;142(2):320–32.
   PubMed Web of Science ®Google Scholar
• Wang G, Chen L, Pan X, Chen J, Wang L, Wang W, et al. The effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signaling. Oncotarget. 2016;7(14):17380–92.
   PubMedGoogle Scholar
• Zhao H, Wang Q, Cheng X, Li X, Li N, Liu T, et al. Inhibitive effect of resveratrol on the inflammation in cultured astrocytes and microglia induced by Abeta1-42. Neuroscience. 2018;379:390–404.
   PubMed Web of Science ®Google Scholar
• Granzotto A, Zatta P. Resveratrol acts not through anti-aggregative pathways but mainly via its scavenging properties against Abeta and Abeta-metal complexes toxicity. PLoS One. 2011;6(6):e21565.
   PubMed Web of Science ®Google Scholar
• Hubbard BP, Sinclair DA. Small molecule SIRT1 activators for the treatment of aging and age-related diseases. Trends Pharmacol Sci. 2014;35(3):146–54.
   PubMed Web of Science ®Google Scholar
• Abuznait AH, Qosa H, Busnena BA, El Sayed KA, Kaddoumi A. Olive-oil-derived oleocanthal enhances beta-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies. ACS Chem Neurosci. 2013;4(6):973–82.
   PubMed Web of Science ®Google Scholar
• Dong S, Huang X, Zhen J, Van Halm-Lutterodt N, Wang J, Zhou C, et al. Dietary vitamin E status Dictates oxidative stress outcomes by modulating effects of fish Oil supplementation in Alzheimer disease model APPswe/PS1dE9 mice. Mol Neurobiol. 2018;55(12):9204–19.
   PubMed Web of Science ®Google Scholar
• Beauchamp GK, Keast RS, Morel D, Lin J, Pika J, Han Q, et al. Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature. 2005;437(7055):45–6.
   PubMed Web of Science ®Google Scholar
• Qosa H, Mohamed LA, Batarseh YS, Alqahtani S, Ibrahim B, LeVine H, et al. Extra-virgin olive oil attenuates amyloid-beta and tau pathologies in the brains of TgSwDI mice. J Nutr Biochem. 2015;26(12):1479–90.
   PubMed Web of Science ®Google Scholar
• Rigacci S, Stefani M. Nutraceutical properties of olive oil polyphenols. An itinerary from cultured cells through animal models to humans. Int J Mol Sci. 2016;17(6): pii: E843.
   PubMed Web of Science ®Google Scholar
• Pang KL, Chin KY. The biological Activities of oleocanthal from a molecular perspective. Nutrients. 2018;20(11):4037–50.
   Google Scholar
• Hosseini B, Berthon BS, Saedisomeolia A, Starkey MR, Collison A, Wark PAB, et al. Effects of fruit and vegetable consumption on inflammatory biomarkers and immune cell populations: a systematic literature review and meta-analysis. Am J Clin Nutr. 2018.
   PubMed Web of Science ®Google Scholar
• Kang JH, Ascherio A, Grodstein F. Fruit and vegetable consumption and cognitive decline in aging women. Ann Neurol. 2005;57(5):713–20.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Kihira T, Kobashi G, Washio M, Sasaki S, Yokoyama T, et al. Fruit and vegetable intake and risk of amyotrophic lateral sclerosis in Japan. Neuroepidemiology. 2009;32(4):251–6.
   PubMed Web of Science ®Google Scholar
• Staubo SC, Aakre JA, Vemuri P, Syrjanen JA, Mielke MM, Geda YE, et al. Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness. Alzheimers Dement. 2017;13(2):168–77.
   PubMed Web of Science ®Google Scholar
• Taylor MK, Sullivan DK, Swerdlow RH, Vidoni ED, Morris JK, Mahnken JD, et al. A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults. Am J Clin Nutr. 2017;106(6):1463–70.
   PubMed Web of Science ®Google Scholar
• Ruhlmann C, Wolk T, Blumel T, Stahn L, Vollmar B, Kuhla A. Long-term caloric restriction in ApoE-deficient mice results in neuroprotection via Fgf21-induced AMPK/mTOR pathway. Aging (Albany NY. 2016;8(11):2777–89.
   PubMedGoogle Scholar
• Schafer MJ, Alldred MJ, Lee SH, Calhoun ME, Petkova E, Mathews PM, et al. Reduction of beta-amyloid and gamma-secretase by calorie restriction in female Tg2576 mice. Neurobiol Aging. 2015;36(3):1293–302.
   PubMed Web of Science ®Google Scholar
• Hadad N, Unnikrishnan A, Jackson JA, Masser DR, Otalora L, Stanford DR, et al. Caloric restriction mitigates age-associated hippocampal differential CG and non-CG methylation. Neurobiol Aging. 2018;67:53–66.
   PubMed Web of Science ®Google Scholar
• Brownlow ML, Joly-Amado A, Azam S, Elza M, Selenica ML, Pappas C, et al. Partial rescue of memory deficits induced by calorie restriction in a mouse model of tau deposition. Behav Brain Res. 2014;271:79–88.
   PubMed Web of Science ®Google Scholar
• Joris PJ, Plat J, Kusters YH, Houben AJ, Stehouwer CD, Schalkwijk CG, et al. Diet-induced weight loss improves not only cardiometabolic risk markers but also markers of vascular function: a randomized controlled trial in abdominally obese men. Am J Clin Nutr. 2017;105(1):23–31.
   PubMed Web of Science ®Google Scholar
• Wycherley TP, Brinkworth GD, Keogh JB, Noakes M, Buckley JD, Clifton PM. Long-term effects of weight loss with a very low carbohydrate and low fat diet on vascular function in overweight and obese patients. J Intern Med. 2010;267(5):452–61.
   PubMed Web of Science ®Google Scholar
• Chapman CD, Schioth HB, Grillo CA, Benedict C. Intranasal insulin in Alzheimer's disease: food for thought. Neuropharmacology. 2018;136(Pt B): 196–201.
   PubMedGoogle Scholar
• de Nazareth AM. Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease. Dement Neuropsychol. 2017;11(2):105–13.
   PubMedGoogle Scholar
• Kleinridders A, Ferris HA, Cai W, Kahn CR. Insulin action in brain regulates systemic metabolism and brain function. Diabetes. 2014;63(7):2232–43.
   PubMed Web of Science ®Google Scholar
• Wijesekara N, Goncalves RA, De Felice FG, Fraser PE. Impaired peripheral glucose homeostasis and Alzheimer's disease. Neuropharmacology. 2018;136(Pt B):172–181.
   PubMedGoogle Scholar
• Wei X, Gao H, Zou J, Liu X, Chen D, Liao J, et al. Contra-directional Coupling of Nur77 and Nurr1 in neurodegeneration: a novel mechanism for Memantine-induced anti-inflammation and anti-mitochondrial impairment. Mol Neurobiol. 2016;53(9):5876–92.
   PubMed Web of Science ®Google Scholar
• Wang R, Chen Z, Fu Y, Wei X, Liao J, Liu X, et al. Plasma cystatin C and high-density lipoprotein Are important biomarkers of Alzheimer's disease and vascular dementia: a cross-sectional study. Front Aging Neurosci. 2017;9(26).
   Google Scholar
• Ingram DK, Zhu M, Mamczarz J, Zou S, Lane MA, Roth GS, et al. Calorie restriction mimetics: an emerging research field. Aging Cell. 2006;5(2):97–108.
   PubMed Web of Science ®Google Scholar
• Mattson MP. Gene-diet interactions in brain aging and neurodegenerative disorders. Ann Intern Med. 2003;139(5 Pt 2):441–4.
   PubMed Web of Science ®Google Scholar
• Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol. 2018;14(3):168–81.
   PubMed Web of Science ®Google Scholar
• Willette AA, Johnson SC, Birdsill AC, Sager MA, Christian B, Baker LD, et al. Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimers Dement. 2015;11(5):504–10 e1.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang NQ, Yan F, Jin H, Zhou SY, Shi JS, et al. Diabetes mellitus and Alzheimer's disease: GSK-3beta as a potential link. Behav Brain Res. 2018;339:57–65.
   PubMed Web of Science ®Google Scholar
• An Y, Varma VR, Varma S, Casanova R, Dammer E, Pletnikova O, et al. Evidence for brain glucose dysregulation in Alzheimer's disease. Alzheimers Dement. 2018;14(3):318–29.
   PubMed Web of Science ®Google Scholar
• Sims-Robinson C, Kim B, Rosko A, Feldman EL. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol. 2010;6(10):551–9.
   PubMed Web of Science ®Google Scholar
• Wood H. Alzheimer disease: Is p-tau the missing link between insulin resistance and AD? Nat Rev Neurol. 2017;13(12):706.
   Web of Science ®Google Scholar
• Rodriguez-Rodriguez P, Sandebring-Matton A, Merino-Serrais P, Parrado-Fernandez C, Rabano A, Winblad B, et al. Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons. Brain. 2017;140(12):3269–85.
   PubMedGoogle Scholar
• Gomez G, Beason-Held LL, Bilgel M, An Y, Wong DF, Studenski S, et al. Metabolic syndrome and amyloid accumulation in the aging brain. J Alzheimers Dis. 2018;65(2):629–39.
   PubMed Web of Science ®Google Scholar
• Najem D, Bamji-Mirza M, Chang N, Liu QY, Zhang W. Insulin resistance, neuroinflammation, and Alzheimer's disease. Rev Neurosci. 2014;25(4):509–25.
   PubMed Web of Science ®Google Scholar
• Hiltunen M, Khandelwal VK, Yaluri N, Tiilikainen T, Tusa M, Koivisto H, et al. Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice. J Cell Mol Med. 2012;16(6):1206–22.
   PubMed Web of Science ®Google Scholar
• Ma L, Dong W, Wang R, Li Y, Xu B, Zhang J, et al. Effect of caloric restriction on the SIRT1/mTOR signaling pathways in senile mice. Brain Res Bull. 2015;116:67–72.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang H, Liu L, Xie A. The role of insulin/IGF-1/PI3K/Akt/GSK3beta signaling in Parkinson's disease dementia. Front Neurosci. 2018;12:73.
   PubMed Web of Science ®Google Scholar
• Matsuda S, Nakagawa Y, Tsuji A, Kitagishi Y, Nakanishi A, Murai T. Implications of PI3K/AKT/PTEN signaling on superoxide dismutases expression and in the pathogenesis of Alzheimer's disease. Diseases. 2018;6(2).
   PubMedGoogle Scholar
• Perera ND, Turner BJ. Ampk signalling and defective energy metabolism in amyotrophic lateral sclerosis. Neurochem Res. 2016;41(3):544–53.
   PubMed Web of Science ®Google Scholar
• Vining EP, Freeman JM, Ballaban-Gil K, Camfield CS, Camfield PR, Holmes GL, et al. A multicenter study of the efficacy of the ketogenic diet. Arch Neurol. 1998;55(11):1433–7.
   PubMedGoogle Scholar
• Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, Wortman JA, et al. Low-carbohydrate nutrition and metabolism. Am J Clin Nutr. 2007;86(2):276–84.
   PubMed Web of Science ®Google Scholar
• Cassady BA, Charboneau NL, Brys EE, Crouse KA, Beitz DC, Wilson T. Effects of low carbohydrate diets high in red meats or poultry, fish and shellfish on plasma lipids and weight loss. Nutr Metab (Lond. 2007;4:23.
   PubMed Web of Science ®Google Scholar
• Villaluz MM, Lomax LB, Jadhav T, Cross JH, Scheffer IE. The ketogenic diet is effective for refractory epilepsy associated with acquired structural epileptic encephalopathy. Dev Med Child Neurol. 2018;60(7):718–23.
   PubMed Web of Science ®Google Scholar
• McDonald TJW, Cervenka MC. Ketogenic diets for adults with highly refractory epilepsy. Epilepsy Curr. 2017;17(6):346–50.
   PubMed Web of Science ®Google Scholar
• Veyrat-Durebex C, Reynier P, Procaccio V, Hergesheimer R, Corcia P, Andres CR, et al. How can a ketogenic diet improve motor function? Front Mol Neurosci. 2018;11:15.
   PubMed Web of Science ®Google Scholar
• Taylor MK, Sullivan DK, Mahnken JD, Burns JM, Swerdlow RH. Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease. Alzheimers Dement (N Y). 2018;4:28–36.
   PubMedGoogle Scholar
• Boison D. New insights into the mechanisms of the ketogenic diet. Curr Opin Neurol. 2017;30(2):187–92.
   PubMed Web of Science ®Google Scholar
• Sada N, Inoue T. Electrical control in neurons by the ketogenic diet. Front Cell Neurosci. 2018;12:208.
   PubMed Web of Science ®Google Scholar
• Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev. 2009;59(2):293–315.
   PubMedGoogle Scholar
• Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond). 2009;6:31.
   PubMed Web of Science ®Google Scholar
• Krikorian R, Shidler MD, Dangelo K, Couch SC, Benoit SC, Clegg DJ. Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol Aging. 2012;33(2):425 e19–27.
   Web of Science ®Google Scholar
• Noh HS, Hah YS, Nilufar R, Han J, Bong JH, Kang SS, et al. Acetoacetate protects neuronal cells from oxidative glutamate toxicity. J Neurosci Res. 2006;83(4):702–9.
   PubMed Web of Science ®Google Scholar
• Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL. D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci U S A. 2000;97(10):5440–4.
   PubMed Web of Science ®Google Scholar
• Puchowicz MA, Emancipator DS, Xu K, Magness DL, Ndubuizu OI, Lust WD, et al. Adaptation to chronic hypoxia during diet-induced ketosis. Adv Exp Med Biol. 2005;566:51–7.
   PubMed Web of Science ®Google Scholar
• Wang BH, Hou Q, Lu YQ, Jia MM, Qiu T, Wang XH, et al. Ketogenic diet attenuates neuronal injury via autophagy and mitochondrial pathways in pentylenetetrazol-kindled seizures. Brain Res. 2018;1678:106–15.
   PubMed Web of Science ®Google Scholar
• Augustin K, Khabbush A, Williams S, Eaton S, Orford M, Cross JH, et al. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol. 2018;17(1):84–93.
   PubMed Web of Science ®Google Scholar
• Tsai SF, Wu HT, Chen PC, Chen YW, Yu M, Wang TF, et al. High-fat diet suppresses the astrocytic process arborization and downregulates the glial glutamate transporters in the hippocampus of mice. Brain Res. 2018;1700:66–77.
   PubMed Web of Science ®Google Scholar
• Ferreiro A, Crook N, Gasparrini AJ, Dantas G. Multiscale evolutionary dynamics of host-associated microbiomes. Cell. 2018;172(6):1216–27.
   PubMed Web of Science ®Google Scholar
• Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The central nervous system and the gut microbiome. Cell. 2016;167(4):915–32.
   PubMed Web of Science ®Google Scholar
• Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC. Gut-Microbiota-Brain axis and Its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther. 2015;37(5):984–95.
   PubMed Web of Science ®Google Scholar
• Grasset E, Puel A, Charpentier J, Collet X, Christensen JE, Terce F, et al. A specific Gut microbiota dysbiosis of type 2 diabetic mice induces GLP-1 resistance through an enteric NO-dependent and gut-brain axis mechanism. Cell Metab. 2017;26(1):278.
   PubMed Web of Science ®Google Scholar
• Wu SC, Cao ZS, Chang KM, Juang JL. Intestinal microbial dysbiosis aggravates the progression of Alzheimer's disease in Drosophila. Nat Commun. 2017;8(1):24.
   PubMedGoogle Scholar
• Lai SW, Liao KF, Lin CL, Sung FC. Irritable bowel syndrome correlates with increased risk of Parkinson's disease in Taiwan. Eur J Epidemiol. 2014;29(1):57–62.
   PubMed Web of Science ®Google Scholar
• Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121–41.
   PubMed Web of Science ®Google Scholar
• Pistollato F, Sumalla Cano S, Elio I, Masias Vergara M, Giampieri F, Battino M. Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr Rev. 2016;74(10):624–34.
   PubMed Web of Science ®Google Scholar
• Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell. 2016;167(6):1469–80 e12.
   PubMed Web of Science ®Google Scholar
• Vogt NM, Romano KA, Darst BF, Engelman CD, Johnson SC, Carlsson CM, et al. The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease. Alzheimers Res Ther. 2018;10(1):124.
   PubMedGoogle Scholar
• Mestre L, Carrillo-Salinas FJ, Mecha M, Feliu A, Espejo C, Alvarez-Cermeno JC, et al. Manipulation of gut microbiota influences immune responses, axon preservation, and motor disability in a model of progressive multiple sclerosis. Front Immunol. 2019;10:1374.
   PubMed Web of Science ®Google Scholar
• Tsai GE, Falk WE, Gunther J, Coyle JT. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment. Am J Psychiatry. 1999;156(3):467–9.
   PubMed Web of Science ®Google Scholar
• Molloy DW, Standish TI, Zhou Q, Guyatt G, Group DS. A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial. Int J Geriatr Psychiatry. 2013;28(5):463–70.
   PubMed Web of Science ®Google Scholar
• Bonfili L, Cecarini V, Cuccioloni M, Angeletti M, Berardi S, Scarpona S, et al. Slab51 probiotic formulation activates SIRT1 pathway promoting antioxidant and neuroprotective effects in an AD mouse model. Mol Neurobiol. 2018;55(10):7987–8000.
   PubMed Web of Science ®Google Scholar
• Minter MR, Zhang C, Leone V, Ringus DL, Zhang X, Oyler-Castrillo P, et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease. Sci Rep. 2016;6:30028.
   PubMed Web of Science ®Google Scholar
• Brandscheid C, Schuck F, Reinhardt S, Schafer KH, Pietrzik CU, Grimm M, et al. Altered gut microbiome composition and tryptic activity of the 5xFAD Alzheimer's mouse model. J Alzheimers Dis. 2017;56(2):775–88.
   PubMed Web of Science ®Google Scholar
• Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Burmann J, et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism Relat Disord. 2016;32:66–72.
   PubMed Web of Science ®Google Scholar
• Yamada T, Shimizu K, Ogura H, Asahara T, Nomoto K, Yamakawa K, et al. Rapid and sustained long-term decrease of fecal short-chain fatty acids in critically Ill patients with systemic inflammatory response syndrome. JPEN J Parenter Enteral Nutr. 2015;39(5):569–77.
   PubMed Web of Science ®Google Scholar
• Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337–41.
   PubMed Web of Science ®Google Scholar
• Goehler LE, Gaykema RP, Opitz N, Reddaway R, Badr N, Lyte M. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun. 2005;19(4):334–44.
   PubMed Web of Science ®Google Scholar
• Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050–5.
   PubMed Web of Science ®Google Scholar
• Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, et al. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov Disord. 2017;32(5):739–49.
   PubMed Web of Science ®Google Scholar
• Haran JP, Bhattarai SK, Foley SE, Dutta P, Ward DV, Bucci V, et al. Alzheimer's disease microbiome is associated with dysregulation of the anti-inflammatory P-Glycoprotein pathway. MBio. 2019;10(3).
   PubMed Web of Science ®Google Scholar
• Hopfner F, Kunstner A, Muller SH, Kunzel S, Zeuner KE, Margraf NG, et al. Gut microbiota in Parkinson disease in a northern German cohort. Brain Res. 2017;1667:41–5.
   PubMed Web of Science ®Google Scholar
• Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, et al. Colonic bacterial composition in Parkinson's disease. Mov Disord. 2015;30(10):1351–60.
   PubMed Web of Science ®Google Scholar
• Shanahan F, van Sinderen D, O'Toole PW, Stanton C. Feeding the microbiota: transducer of nutrient signals for the host. Gut. 2017;66(9):1709–17.
   PubMed Web of Science ®Google Scholar
• Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488(7410):178–84.
   PubMed Web of Science ®Google Scholar
• Sonnenburg ED, Sonnenburg JL. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab. 2014;20(5):779–86.
   PubMed Web of Science ®Google Scholar
• Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105–8.
   PubMed Web of Science ®Google Scholar
• Delzenne NM, Neyrinck AM, Cani PD. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact. 2011;10(Suppl 1):S10.
   PubMedGoogle Scholar
• Le Couteur DG, Solon-Biet S, Cogger VC, Mitchell SJ, Senior A, de Cabo R, et al. The impact of low-protein high-carbohydrate diets on aging and lifespan. Cell Mol Life Sci. 2016;73(6):1237–52.
   PubMed Web of Science ®Google Scholar
• Guarente L, Picard F. Calorie restriction–the SIR2 connection. Cell. 2005;120(4):473–82.
   PubMed Web of Science ®Google Scholar
• Solon-Biet SM, Mitchell SJ, de Cabo R, Raubenheimer D, Le Couteur DG, Simpson SJ. Macronutrients and caloric intake in health and longevity. J Endocrinol. 2015;226(1):R17–28.
   PubMed Web of Science ®Google Scholar
• Simpson SJ, Le Couteur DG, Raubenheimer D. Putting the balance back in diet. Cell. 2015;161(1):18–23.
   PubMed Web of Science ®Google Scholar
• Simpson SJ, Raubenheimer D. Obesity: the protein leverage hypothesis. Obes Rev. 2005;6(2):133–42.
   PubMed Web of Science ®Google Scholar
• Calikoglu A, Karayal A, D'Ercole A. Nutritional regulation of IGF-I expression during brain development in mice. Pediatr Res. 2001;49(2):197–202.
   PubMed Web of Science ®Google Scholar
• Trejo JL, Carro E, Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci. 2001;21(5):1628–34.
   PubMed Web of Science ®Google Scholar
• Mishra N, Lata S, Deshmukh P, Kamat K, Surolia A, Banerjee T. Insulin signaling pathway protects neuronal cell lines by Sirt3 mediated IRS2 activation. Biofactors. 2018;44(3):224–36.
   PubMed Web of Science ®Google Scholar
• Lee J, Baek H, Kim SH, Park Y. Association between estimated total daily energy expenditure and stage of amyotrophic lateral sclerosis. Nutrition. 2017;33:181–6.
   PubMed Web of Science ®Google Scholar